A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

Abstract Purpose This investigation sought to examine the efficacy and safety of low-dose apatinib used alongside chemotherapy in the clinical management of patients with metastatic triple-negative breast cancer (TNBC) within a real-world setting, whilst comparing the outcomes with those treated sol...

Full description

Bibliographic Details
Main Authors: Weiwei Huang, Chenxi Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Lili Wang, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Cancer
Subjects:
Apatinib
Triple-negative breast cancer
Real-world study
Online Access:https://doi.org/10.1186/s12885-023-11790-6

Internet

https://doi.org/10.1186/s12885-023-11790-6

Similar Items